A study [88] showed that Tregs are more sensitive to GX-15 than CD4-Teff in peripheral blood monocytes from ovarian cancer patients, so GX-15 significantly inhibits Treg function with little or no impact on Teff function. This evidence concerns the gene CD4 and ovarian cancer.